NCT03721926 is a NA clinical trial of Usual Care in Other Cancer, sponsored by Massachusetts General Hospital.

Who is sponsoring NCT03721926?

NCT03721926 is sponsored by Massachusetts General Hospital.

What drugs are being tested in NCT03721926?

Interventions in NCT03721926: Usual Care, Geriatric Oncology Collaborative Care.

What condition does NCT03721926 study?

NCT03721926 studies Other Cancer.

Is NCT03721926 still recruiting?

NCT03721926 is currently completed. Last updated 7 April 2022.

Last reviewed 2022-04-07 · How we verify

NCT03721926

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Geriatric Oncology Collaborative Care Intervention for Older Adults With Advanced Cancer

Completed NA Last updated 7 April 2022

What this trial tests

NA trial testing Usual Care in Other Cancer in 91 participants. Completed in 31 March 2022.

Timeline

14 February 2019

Primary endpoint
31 March 2022

31 March 2022

Quick facts

Lead sponsor	Massachusetts General Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	91
Start date	14 February 2019
Primary completion	31 March 2022
Estimated completion	31 March 2022
Sites	1 location across United States

Drugs / interventions tested

Usual Care
Geriatric Oncology Collaborative Care

Conditions studied

Other Cancer — all drugs for Other Cancer →

Sponsor

Massachusetts General Hospital

Who can join

65 and older, any sex, with Other Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to develop a geriatric oncology collaborative care intervention to enhance the quality of life, symptom burden, and functional outcomes of older adults with advanced gastrointestinal (GI) and genitourinary (GU) cancers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Usual Care

Trials testing the same drug.

NCT07513805 — Implementation of Routine Walking Speed Measurements in Older Veterans · NA · not yet recruiting
NCT07225062 — Improving HIV Prevention and Substance Use Post-Sexual Assault Services · NA · not yet recruiting
NCT07202975 — RE-SCALE: Rehabilitation Engagement and Scaled Access With eXtended Reality and Artificial Intelligence · NA · not yet recruiting
NCT05744869 — SBAT for Health Equity · NA · not yet recruiting
NCT07380932 — Catheter Ablation for AF in Patients With Severe Mitral Regurgitation After Successful Transcatheter Mitral-Valve Repair · NA · not yet recruiting

Other recruiting trials for Other Cancer

Currently open trials in the same condition.

NCT06397651 — A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live CoActive Exercise Coaching and Personal · NA · active not recruiting
NCT06103669 — Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS) · NA · recruiting
NCT04585750 — The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) · Phase 1, PHASE2 · recruiting
NCT04340024 — Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients · recruiting
NCT03752268 — Development of an Intervention to Enhance Cancer Pain Management · NA · active not recruiting

Other Massachusetts General Hospital trials

Trials by the same sponsor.

NCT03585946 — Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis · withdrawn
NCT07214831 — A Feasibility and Acceptability Study of a Large Language Model-based Chatbot for Brief Alcohol Intervention Among Emerg · NA · not yet recruiting
NCT06686901 — A Randomized Controlled Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior · NA · not yet recruiting
NCT05854212 — Behavioral Economics to Implement Nutrition Ranking in Food Pantries · NA · not yet recruiting
NCT07323446 — The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03721926 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Massachusetts General Hospital
Last refreshed: 7 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03721926.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing